Inhibitory effects of dextrorotatory morphinans on the human 5-HT(3A) receptor expressed in Xenopus oocytes: Involvement of the N-terminal domain of the 5-HT(3A) receptor

European Journal of Pharmacology
Byung-Hwan LeeSeung-Yeol Nah

Abstract

We previously developed a series of dextromethorphan (DM, 3-methoxy-17-methylmorphinan) analogs modified at positions 3 and 17 of the morphinan ring system. Recent reports have shown that DM attenuates abdominal pain caused by irritable bowel syndrome, and multidrug regimens that include DM prevent nausea/vomiting following cancer surgery. However, little is known regarding the molecular mechanisms underlying the beneficial effects of DM. Here, we investigated the effects of DM, 3 of its analogs (AM, 3-allyloxy-17-methoxymorphian; CM, 3-cyclopropyl-17-methoxymorphinan; and DF, 3-methyl-17-methylmorphinan), and 1 of its metabolites (HM, 3-methoxymorphinan) on the activity of the human 5-HT(3A) receptor channel expressed in Xenopus laevis oocytes, using the 2-microelectrode voltage clamp technique. We found that intra-oocyte injection of human 5-HT(3A) receptor cRNAs elicited an inward current (I(5-HT)) in the presence of 5-HT. Cotreatment with AM, CM, DF, DM, or HM inhibited I(5-HT) in a dose-dependent, voltage-independent, and reversible manner. The IC(50) values for AM, CM, DF, DM, and HM were 24.5±1.4, 21.5±4.2, 132.6±35.8, 181.3±23.5, and 191.3±31.5μM, respectively. The IC(50) values of AM and CM were 7-fold lower than that ...Continue Reading

References

Mar 1, 1995·Trends in Neurosciences·M O Ortells, G G Lunt
Jun 27, 2001·Bioorganic & Medicinal Chemistry Letters·H C KimP H Lee
Sep 13, 2003·The Journal of Biological Chemistry·Xiang-Qun HuForrest F Weight
May 19, 2004·British Journal of Pharmacology·Sang Min JeongSeung-Yeol Nah
Jan 25, 2005·Journal of Neurochemistry·Marianne L JensenPhilip K Ahring
Jul 15, 2005·Molecular Pharmacology·Jun-Ho LeeSeung-Yeol Nah
Jan 30, 2007·Neuropharmacology·Byung-Hwan LeeSeung-Yeol Nah
Mar 10, 2007·European Journal of Pharmacology·Jun-Ho LeeSeung-Yeol Nah
Dec 15, 2010·The Journal of Pain : Official Journal of the American Pain Society·QiQi ZhouG Nicholas Verne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.